Nowadays, most adults with cancer are hesitant to join clinical trials with only 3 to 5 percent of cancer patients volunteering to participate. As a result, one in five cancer studies fail to draw enough participants to determine whether or not the new treatment works, states a Fred Hutchinson Cancer Research Center and the University of Washington study published in December.
Read Full Article »
